Summary
Objective. To explore the association between eating disorders (EDs) prior to the use of clozapine/olanzapine (pre-clozapine/olanzapine EDs) and after initiation of these antipsychotics (post-clozapine/olanzapine EDs).
Method. Sixty-four consecutively admitted patients receiving clozapine/olanzapine were screened using the M-Composite International Diagnostic Interview (M-CIDI) to identify subjects with pre-clozapine/olanzapine EDs (DSM-IV criteria). We investigated post-clozapine/olanzapine EDs and binge eating behavior using the Questionnaire on Eating and Weight Patterns (QEWP) and used the Naranjo probability scale as objective causality assessment.
Results. Post-clozapine/olanzapine EDs were significantly more frequent in patients with pre-clozapine/olanzapine EDs (5 of 6) when compared to patients without pre-clozapine/olanzapine EDs (4 of 58) [χ2 = 26.29; df = 1; p < 0.001] [odds ratio (OR) 67.5; 95% CI: 6.3–25.8]. According to the Naranjo probability scale, recurrence or deterioration of EDs in patients with prior EDs was definitely (n = 1) or probably (n = 4) related to the intake of clozapine/olanzapine.
Conclusion. Clozapine/olanzapine may induce recurrence or deterioration of binge eating symptomatology or full-blown EDs in patients with prior EDs.
Similar content being viewed by others
References
DB Allison JL Mentore M Heo LP Chandler JC Cappelleri MC Infante PJ Weiden (1999) ArticleTitleAntipsychotic-induced weight gain: a comprehensive research synthesis Am J Psychiatry 156 1686–1696 Occurrence Handle1:STN:280:DC%2BD3c%2FhvFWmug%3D%3D Occurrence Handle10553730
TD Brewerton M Shannon (1992) ArticleTitlePossible clozapine exacerbation of bulimia nervosa Am J Psychiatry 149 1408–1409 Occurrence Handle1:STN:280:DyaK38vhtFemsw%3D%3D Occurrence Handle1530082
T Brömel WF Blum A Ziegler E Schulz M Bender C Fleischhaker H Remschmidt JC Krieg J Hebebrand (1998) ArticleTitleSerum leptin levels increase rapidly after initiation of clozapine therapy Mol Psychiatry 3 76–80 10.1038/sj.mp.4000352 Occurrence Handle10.1038/sj.mp.4000352 Occurrence Handle9491817
JA Costa e Silva N Alvarez G Mazzoti WF Gattaz J Ospina V Larach S Starkstein D Oliva L Cousins M Tohen CC Taylor J Wang PV Tran (2001) ArticleTitleOlanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: results of a multicenter, collaborative trial in Latin America J Clin Psychopharmacol 21 375–381 10.1097/00004714-200108000-00004 Occurrence Handle10.1097/00004714-200108000-00004 Occurrence Handle11476121
DN Crockford G Fisher P Barker (1997) ArticleTitleRisperidone, weight gain, and bulimia nervosa Can J Psychiatry 42 326–327 Occurrence Handle1:STN:280:DyaK2s3ntVSktw%3D%3D Occurrence Handle9114956
SM Dursun S Devarajan (2000) ArticleTitleClozapine weight gain, plus topiramate weight loss Can J Psychiatry 45 198 Occurrence Handle1:STN:280:DC%2BD3c3gslartA%3D%3D Occurrence Handle10742883
CG Fairburn MJ Cooper (1994) ArticleTitleChanges in selective information processing with three psychological treatments for bulimia nervosa Br J Clin Psychol 33 353–356 Occurrence Handle7994221
C Foulon (2003) ArticleTitleSchizophrenia and eating disorders Encephale 29 463–466 Occurrence Handle1:STN:280:DC%2BD3srktFyhuw%3D%3D Occurrence Handle14615697
R Geist R Davis M Heinman (1998) ArticleTitleBinge/purge symptoms and comorbidity in adolescents with eating disorders Can J Psychiatry 43 507–512 Occurrence Handle1:STN:280:DyaK1czhslCiug%3D%3D Occurrence Handle9653536
B Herpertz-Dahlmann B Müller S Herpertz N Heussen J Hebebrand H Remschmidt (2001) ArticleTitleProspective 10-year follow-up in adolescent anorexia nervosa — course, outcome, psychiatric comorbidity, and psychosocial adaptation J Child Psychol Psychiatry 42 603–612 10.1017/S0021963001007326 Occurrence Handle10.1111/1469-7610.00756 Occurrence Handle1:STN:280:DC%2BD38%2Fit1eltQ%3D%3D Occurrence Handle11464965
A Joos T Steinert (1997) ArticleTitleComorbidity of schizophrenia and bulimic anorexia. A case with forensic implications [German] Nervenarzt 68 417–420 10.1007/s001150050144 Occurrence Handle10.1007/s001150050144 Occurrence Handle1:STN:280:DyaK2szntVartw%3D%3D Occurrence Handle9280852
R Leadbetter M Shutty D Pavalonis V Vieweg P Higgins M Downs (1992) ArticleTitleClozapine-induced weight gain: prevalence and clinical relevance Am J Psychiatry 149 68–72 Occurrence Handle1:STN:280:DyaK38%2FpsFCjtw%3D%3D Occurrence Handle1728188
E Levy HC Margolese G Chouinard (2002) ArticleTitleTopiramate produced weight loss following olanzapine-induced weight gain in schizophrenia J Clin Psychiatry 63 1045 Occurrence Handle12469686
SL McElroy LM Arnold NA Shapira PE Keck SuffixJr NR Rosenthal MR Karim M Kamin JI Hudson (2003) ArticleTitleTopiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial Am J Psychiatry 160 255–261 10.1176/appi.ajp.160.2.255 Occurrence Handle10.1176/appi.ajp.160.2.255 Occurrence Handle12562571
C Mehler C Wewetzer U Schulze A Warnke F Theisen RW Dittmann (2001) ArticleTitleOlanzapine in children and adolescents with chronic anorexia nervosa. A study of five cases Eur Child Adolesc Psychiatry 10 151–157 10.1007/s007870170039 Occurrence Handle10.1007/s007870170039 Occurrence Handle1:STN:280:DC%2BD38%2FitlCltw%3D%3D Occurrence Handle11469288
MP Mussell JE Mitchell M de Zwaan RD Crosby HC Seim SJ Crow (1996) ArticleTitleClinical characteristics associated with binge eating in obese females: a descriptive study Int J Obes Relat Metab Disord 20 324–331 Occurrence Handle1:STN:280:DyaK283ovFOnsQ%3D%3D Occurrence Handle8680459
CA Naranjo U Busto EM Sellers P Sandor I Ruiz EA Roberts E Janecek C Domecq DJ Greenblatt (1981) ArticleTitleA method for estimating the probability of adverse drug reactions Clin Pharmacol Ther 30 239–245 Occurrence Handle1:CAS:528:DyaL3MXltVygsLk%3D Occurrence Handle7249508 Occurrence Handle10.1038/clpt.1981.154
F Rosenow S Knake J Hebebrand (2002) ArticleTitleTopiramate and anorexia nervosa Am J Psychiatry 159 2112–2113 10.1176/appi.ajp.159.12.2112-a Occurrence Handle10.1176/appi.ajp.159.12.2112-a Occurrence Handle12450969
JH Rosenvinge M Martinussen E Ostensen (2000) ArticleTitleThe comorbidity of eating disorders and personality disorders: a metaanalytic review of studies published between 1983 and 1998 Eat Weight Disord 5 52–61 Occurrence Handle1:STN:280:DC%2BD3M%2FntlOnsw%3D%3D Occurrence Handle10941603
M Schüler-Springorum J Hebebrand PM Wehmeier H Remschmidt (2002) ArticleTitleIs topiramate effective for weight loss in neuroleptic-induced obesity? 2 case reports [German] Z Kinder Jugendpsychiatr Psychother 30 51–58 10.1024//1422-4917.30.1.51 Occurrence Handle10.1024//1422-4917.30.1.51 Occurrence Handle11876083
NA Shapira TD Goldsmith SL McElroy (2000) ArticleTitleTreatment of binge-eating disorder with topiramate: a clinical case series J Clin Psychiatry 61 368–372 Occurrence Handle1:CAS:528:DC%2BD3cXktFGhtr0%3D Occurrence Handle10847312 Occurrence Handle10.4088/JCP.v61n0508
RL Spitzer S Yanovski T Wadden R Wing MD Marcus A Stunkard M Devlin J Mitchell D Hasin RL Horne (1993) ArticleTitleBinge eating disorder: its further validation in a multisite study Int J Eat Disord 13 137–153 10.1002/1098-108X(199303)13:2<161::AID-EAT2260130204>3.0.CO;2-R Occurrence Handle10.1002/1098-108X(199303)13:2<161::AID-EAT2260130204>3.0.CO;2-R Occurrence Handle1:STN:280:DyaK3s3jsl2itg%3D%3D Occurrence Handle8477283
RH Striegel-Moore V Garvin FA Dohm RA Rosenheck (1999) ArticleTitlePsychiatric comorbidity of eating disorders in men: a national study of hospitalized veterans Int J Eat Disord 25 399–404 10.1002/(SICI)1098-108X(199905)25:4<399::AID-EAT4>3.0.CO;2-0 Occurrence Handle10.1002/(SICI)1098-108X(199905)25:4<399::AID-EAT4>3.0.CO;2-0 Occurrence Handle1:STN:280:DyaK1M3hvV2ktw%3D%3D Occurrence Handle10202650
FM Theisen S Cichon A Linden M Martin H Remschmidt J Hebebrand (2001) ArticleTitleClozapine and weight gain Am J Psychiatry 158 816 10.1176/appi.ajp.158.5.816 Occurrence Handle10.1176/appi.ajp.158.5.816 Occurrence Handle1:STN:280:DC%2BD3M3ovVGltg%3D%3D Occurrence Handle11329412
FM Theisen A Linden IR König M Martin H Remschmidt J Hebebrand (2003) ArticleTitleSpectrum of binge eating symptomatology in patients treated with clozapine and olanzapine J Neural Transm 110 111–121 Occurrence Handle1:CAS:528:DC%2BD3sXltlCitw%3D%3D Occurrence Handle12541016
HU Wittchen G Lachner U Wunderlich H Pfister (1998a) ArticleTitleTest-retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI) Soc Psychiatry Psychiatr Epidemiol 33 568–578 10.1007/s001270050095 Occurrence Handle10.1007/s001270050095 Occurrence Handle1:STN:280:DyaK1M%2FitVKltA%3D%3D
HU Wittchen CB Nelson G Lachner (1998b) ArticleTitlePrevalence of mental disorders and psychosocial impairments in adolescents and young adults Psychol Med 28 109–112 10.1017/S0033291797005928 Occurrence Handle10.1017/S0033291797005928 Occurrence Handle1:STN:280:DyaK1c7ksVKrsw%3D%3D
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gebhardt, S., Haberhausen, M., Krieg, JC. et al. Clozapine/olanzapine-induced recurrence or deterioration of binge eating-related eating disorders. J Neural Transm 114, 1091–1095 (2007). https://doi.org/10.1007/s00702-007-0663-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-007-0663-2